INSM - Insmed Inc
IEX Last Trade
76.45
0.120 0.157%
Share volume: 1,721,936
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$76.33
0.12
0.16%
Fundamental analysis
38%
Profitability
41%
Dept financing
25%
Liquidity
66%
Performance
30%
Performance
5 Days
-3.01%
1 Month
4.88%
3 Months
34.20%
6 Months
172.81%
1 Year
246.33%
2 Year
220.09%
Key data
Stock price
$76.45
DAY RANGE
N/A - N/A
52 WEEK RANGE
$21.92 - $80.53
52 WEEK CHANGE
$2.38
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: William Lewis
Region: US
Website: http://www.insmed.com/
Employees: 778
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.insmed.com/
Employees: 778
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Recent news